Pain
From the Journals
Are newer migraine therapies better? It depends
“Triptans will be around for a long time, but the newer medications are here to stay,”
Latest News
Neurologist guilty of overprescribing thousands of doses of painkillers
A federal jury found William R. Bauer, 84, of Port Clinton, Ohio, ...
Literature Review
Erenumab beats topiramate for migraine in first head-to-head trial
The findings suggest that erenumab may help overcome longstanding issues with migraine medication adherence.
Literature Review
Small fiber neuropathy is rising in the U.S., but why is a mystery
Increased BMI appears to be a risk factor for this disorder.
Conference Coverage
Patients given NSAIDs over antiemetics for headaches spend less time in the ED
Treatment with oral drugs only was associated with an 11% reduction of length of stay, compared with treatment with parenteral medication only.
Conference Coverage
DIY nerve stimulation effective in episodic migraine
Participants in a new study applied neurostimulation for a continuous 2-hour period within 4 hours of a migraine attack.
Latest News
FDA approves combo pill for severe, acute pain
Seglentis contains 56 mg of celecoxib and 44 mg of tramadol.
From the Journals
Tramadol linked to higher risk of mortality, compared with codeine
Tramadol is widely used for noncancer pain but, as compared with codeine, it was associated with a higher risk for adverse outcomes, including...
FDA/CDC
FDA OKs new high-dose naloxone product for opioid overdose
“The higher intramuscular doses of naloxone in ZIMHI should result in more rapid and higher levels of naloxone in the systemic circulation.”
From the Journals
New antimigraine drugs linked with less risk for adverse events
The safety and efficacy of new antimigraine treatments were compared with current standard therapy, in a new systematic review.
Conference Coverage
Lumbar epidural steroid jab lowers bone formation in older women
The extent and duration of the effects of a lumbar epidural steroid injection suggest that patients who receive multiple injections may be at...